These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 2167738)

  • 21. Alterations by glyburide of effects of BRL 34915 and P 1060 on contraction, 86Rb efflux and the maxi-K+ channel in rat portal vein.
    Hu SL; Kim HS; Okolie P; Weiss GB
    J Pharmacol Exp Ther; 1990 May; 253(2):771-7. PubMed ID: 2110977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that pinacidil may promote the opening of ATP-sensitive K+ channels yet inhibit the opening of Ca2(+)-activated K+ channels in K(+)-contracted canine mesenteric artery.
    Masuzawa K; Matsuda T; Asano M
    Br J Pharmacol; 1990 May; 100(1):143-9. PubMed ID: 2115387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of racemic cromakalim, BRL 38226 and levcromakalim on the membrane potential of the rat aorta and of BRL 38226 on the contractile activity of the rat aorta and portal vein.
    Bishop BE; Doggrell SA
    J Auton Pharmacol; 1994 Apr; 14(2):99-108. PubMed ID: 8051202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dualistic mode of action of the vasodilator drug, nicorandil, differentiated by glibenclamide in 86Rb flux studies in rabbit isolated vascular smooth muscle.
    Kreye VA; Lenz T; Theiss U
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):70-5. PubMed ID: 1827659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
    Piper I; Minshall E; Downing SJ; Hollingsworth M; Sadraei H
    Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle.
    Perez-Vizcaino F; Casis O; Rodriguez R; Gomez LA; Garcia Rafanell J; Tamargo J
    Br J Pharmacol; 1993 Nov; 110(3):1165-71. PubMed ID: 8298804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The individual enantiomers of cis-cromakalim possess K+ channel opening activity.
    Quast U; Villhauer EB
    Eur J Pharmacol; 1993 Apr; 245(2):165-71. PubMed ID: 8491256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasorelaxing effect in rat thoracic aorta caused by fraxinellone and dictamine isolated from the Chinese herb Dictamnus dasycarpus Turcz: comparison with cromakalim and Ca2+ channel blockers.
    Yu SM; Ko FN; Su MJ; Wu TS; Wang ML; Huang TF; Teng CM
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):349-55. PubMed ID: 1377790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of Ki1769, a novel vasodilator, in isolated rat aorta.
    Kashiwabara T; Nakajima T; Kasai H; Nakajima S; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 327(2):175-83. PubMed ID: 7979826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the K+ efflux stimulating vasodilator BRL 34915 on 86Rb+ efflux and spontaneous activity in guinea-pig portal vein.
    Quast U
    Br J Pharmacol; 1987 Jul; 91(3):569-78. PubMed ID: 3038244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 8-(Diethylamino)-octyl-3,4,5-trimethoxybenzoate inhibits cromakalim-induced 86Rb efflux from the rat aorta.
    Lodge NJ; Halaka NN
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1399-405. PubMed ID: 8510016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
    Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
    J Pharmacol Exp Ther; 1990 May; 253(2):586-93. PubMed ID: 2160002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tedisamil (KC 8857) differentially inhibits the 86Rb+ efflux-stimulating and vasorelaxant properties of cromakalim.
    Bray K; Quast U
    Eur J Pharmacol; 1991 Jul; 200(1):163-5. PubMed ID: 1769368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of putative K+ channel activator BRL-34915 on arterial contraction and 86Rb efflux.
    Cox RH
    J Pharmacol Exp Ther; 1990 Jan; 252(1):51-9. PubMed ID: 2299602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat.
    Buckingham RE; Hamilton TC; Howlett DR; Mootoo S; Wilson C
    Br J Pharmacol; 1989 May; 97(1):57-64. PubMed ID: 2497925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro studies on the mode of action of pinacidil.
    Weston AH; Bray KM; Duty S; McHarg AD; Newgreen DT; Southerton JS
    Drugs; 1988; 36 Suppl 7():10-28. PubMed ID: 2855517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potassium channel opening action of pinacidil; studies using biochemical, ion flux and microelectrode techniques.
    Southerton JS; Weston AH; Bray KM; Newgreen DT; Taylor SG
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):310-8. PubMed ID: 2848206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Action of KC-399, a newly synthesized potassium channel opener, on mechanical activity and 86Rb efflux in rat aorta.
    Tamura K; Suzuki Y; Yoshida S; Nabata H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):220-6. PubMed ID: 7511750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological characterization of nicorandil by 86Rb efflux and isometric vasorelaxation studies in vascular smooth muscle.
    Kreye VA; Lenz T; Pfründer D; Theiss U
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S8-12. PubMed ID: 1282181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The involvement of potassium channels in the action of ciclazindol in rat portal vein.
    Noack T; Edwards G; Deitmer P; Greengrass P; Morita T; Andersson PO; Criddle D; Wyllie MG; Weston AH
    Br J Pharmacol; 1992 May; 106(1):17-24. PubMed ID: 1504725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.